Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 24385 | 314 | 30.1 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
| 233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
| 889 | 2 | FLUOROQUINOLONES//QUINOLONES//CIPROFLOXACIN | 11411 |
| 24385 | 1 | MANAGEMENT HLTH NPMC//CIPROFLOXACIN//CYST FIBROSIS PULM CLIN TREATMENT | 314 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | MANAGEMENT HLTH NPMC | address | 194492 | 1% | 100% | 2 |
| 2 | CIPROFLOXACIN | authKW | 165957 | 20% | 3% | 63 |
| 3 | CYST FIBROSIS PULM CLIN TREATMENT | address | 109398 | 1% | 38% | 3 |
| 4 | BG UNIV HOSP BERGMANNSHEIL MOL ONCOL WOUND | address | 97246 | 0% | 100% | 1 |
| 5 | BIOL OXIDAT ST S LBSO LCR7 817 | address | 97246 | 0% | 100% | 1 |
| 6 | BONE MARROW INVIVO | authKW | 97246 | 0% | 100% | 1 |
| 7 | CARBOXYLATED QUINOLONES | authKW | 97246 | 0% | 100% | 1 |
| 8 | CHAIR MMED BIOL | address | 97246 | 0% | 100% | 1 |
| 9 | CHROMATID TYPE BREAKAGE | authKW | 97246 | 0% | 100% | 1 |
| 10 | CIPROFLOXACIN CYCLOSPORINE A RAT | authKW | 97246 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1490 | 41% | 0% | 128 |
| 2 | Microbiology | 934 | 24% | 0% | 74 |
| 3 | Infectious Diseases | 641 | 14% | 0% | 44 |
| 4 | Toxicology | 278 | 10% | 0% | 30 |
| 5 | Immunology | 141 | 12% | 0% | 37 |
| 6 | Medicine, Research & Experimental | 87 | 7% | 0% | 23 |
| 7 | Oncology | 72 | 10% | 0% | 31 |
| 8 | Transplantation | 34 | 3% | 0% | 8 |
| 9 | Chemistry, Medicinal | 33 | 4% | 0% | 12 |
| 10 | Andrology | 28 | 1% | 0% | 2 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | MANAGEMENT HLTH NPMC | 194492 | 1% | 100% | 2 |
| 2 | CYST FIBROSIS PULM CLIN TREATMENT | 109398 | 1% | 38% | 3 |
| 3 | BG UNIV HOSP BERGMANNSHEIL MOL ONCOL WOUND | 97246 | 0% | 100% | 1 |
| 4 | BIOL OXIDAT ST S LBSO LCR7 817 | 97246 | 0% | 100% | 1 |
| 5 | CHAIR MMED BIOL | 97246 | 0% | 100% | 1 |
| 6 | HUAI HE CLIN | 97246 | 0% | 100% | 1 |
| 7 | INFECT DIS TRANSPLANTAT IMMUNOL | 97246 | 0% | 100% | 1 |
| 8 | IVF SUBUNIT | 97246 | 0% | 100% | 1 |
| 9 | MED E INFECT DIS UNIT | 97246 | 0% | 100% | 1 |
| 10 | NAZARBAYEV UNIV INNOVAT SYST PRIVATE | 97246 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 4463 | 11% | 0% | 33 |
| 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 4105 | 7% | 0% | 23 |
| 3 | LYMPHOKINE RESEARCH | 1337 | 1% | 1% | 2 |
| 4 | JOURNAL OF VETERINARY RESEARCH | 1312 | 0% | 1% | 1 |
| 5 | IMMUNOPHARMACOLOGY | 1164 | 1% | 0% | 4 |
| 6 | CHEMOTHERAPY | 951 | 2% | 0% | 5 |
| 7 | JOURNAL OF INFECTION AND CHEMOTHERAPY | 769 | 1% | 0% | 3 |
| 8 | ANASTHESIE INTENSIVTHERAPIE NOTFALLMEDIZIN | 557 | 0% | 1% | 1 |
| 9 | INTERNATIONAL JOURNAL OF PHARMACOLOGY | 517 | 1% | 0% | 2 |
| 10 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 470 | 1% | 0% | 3 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CIPROFLOXACIN | 165957 | 20% | 3% | 63 | Search CIPROFLOXACIN | Search CIPROFLOXACIN |
| 2 | BONE MARROW INVIVO | 97246 | 0% | 100% | 1 | Search BONE+MARROW+INVIVO | Search BONE+MARROW+INVIVO |
| 3 | CARBOXYLATED QUINOLONES | 97246 | 0% | 100% | 1 | Search CARBOXYLATED+QUINOLONES | Search CARBOXYLATED+QUINOLONES |
| 4 | CHROMATID TYPE BREAKAGE | 97246 | 0% | 100% | 1 | Search CHROMATID+TYPE+BREAKAGE | Search CHROMATID+TYPE+BREAKAGE |
| 5 | CIPROFLOXACIN CYCLOSPORINE A RAT | 97246 | 0% | 100% | 1 | Search CIPROFLOXACIN+CYCLOSPORINE+A+RAT | Search CIPROFLOXACIN+CYCLOSPORINE+A+RAT |
| 6 | CLYNDAMICIN | 97246 | 0% | 100% | 1 | Search CLYNDAMICIN | Search CLYNDAMICIN |
| 7 | CMPP | 97246 | 0% | 100% | 1 | Search CMPP | Search CMPP |
| 8 | CYCLOPROPYL MOIETY | 97246 | 0% | 100% | 1 | Search CYCLOPROPYL+MOIETY | Search CYCLOPROPYL+MOIETY |
| 9 | CYCLOSPORINE A CIPROFLOXACIN RAT | 97246 | 0% | 100% | 1 | Search CYCLOSPORINE+A+CIPROFLOXACIN+RAT | Search CYCLOSPORINE+A+CIPROFLOXACIN+RAT |
| 10 | FLUOROQUINOLONES ANTI CANCER | 97246 | 0% | 100% | 1 | Search FLUOROQUINOLONES+ANTI+CANCER | Search FLUOROQUINOLONES+ANTI+CANCER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | RIESBECK, K , (2002) IMMUNOMODULATING ACTIVITY OF QUINOLONES: REVIEW.JOURNAL OF CHEMOTHERAPY. VOL. 14. ISSUE 1. P. 3-12 | 36 | 82% | 27 |
| 2 | DALHOFF, A , SHALIT, L , (2003) IMMUNOMODULATORY EFFECTS OF QUINOLONES.LANCET INFECTIOUS DISEASES. VOL. 3. ISSUE 6. P. 359-371 | 43 | 43% | 143 |
| 3 | DALHOFF, A , (2005) IMMUNOMODULATORY ACTIVITIES OF FLUOROQUINOLONES.INFECTION. VOL. 33. ISSUE . P. 55-70 | 44 | 41% | 72 |
| 4 | ERIKSSON, E , FORSGREN, A , RIESBECK, K , (2003) SEVERAL GENE PROGRAMS ARE INDUCED IN CIPROFLOXACIN-TREATED HUMAN LYMPHOCYTES AS REVEALED BY MICROARRAY ANALYSIS.JOURNAL OF LEUKOCYTE BIOLOGY. VOL. 74. ISSUE 3. P. 456-463 | 16 | 89% | 16 |
| 5 | GURTOWSKA, N , KLOSKOWSKI, T , DREWA, T , (2010) CIPROFLOXACIN CRITERIA IN ANTIMICROBIAL PROPHYLAXIS AND BLADDER CANCER RECURRENCE.MEDICAL SCIENCE MONITOR. VOL. 16. ISSUE 10. P. RA218-RA223 | 21 | 53% | 4 |
| 6 | SHALIT, I , (1991) IMMUNOLOGICAL ASPECTS OF NEW QUINOLONES.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. VOL. 10. ISSUE 4. P. 262-266 | 20 | 95% | 40 |
| 7 | SURESH, N , NAGESH, HN , SEKHAR, KVGC , KUMAR, A , SHIRAZI, AN , PARANG, K , (2013) SYNTHESIS OF NOVEL CIPROFLOXACIN ANALOGUES AND EVALUATION OF THEIR ANTI-PROLIFERATIVE EFFECT ON HUMAN CANCER CELL LINES.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 23. ISSUE 23. P. 6292 -6295 | 13 | 68% | 4 |
| 8 | KOZIEL, R , SZCZEPANOWSKA, J , MAGALSKA, A , PIWOCKA, K , DUSZYNSKI, J , ZABLOCKI, K , (2010) CIPROFLOXACIN INHIBITS PROLIFERATION AND PROMOTES GENERATION OF ANEUPLOIDY IN JURKAT CELLS.JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 61. ISSUE 2. P. 233-239 | 15 | 63% | 14 |
| 9 | TSIVKOVSKII, R , SABET, M , TARAZI, Z , GRIFFITH, DC , LOMOVSKAYA, O , DUDLEY, MN , (2011) LEVOFLOXACIN REDUCES INFLAMMATORY CYTOKINE LEVELS IN HUMAN BRONCHIAL EPITHELIA CELLS: IMPLICATIONS FOR AEROSOL MP-376 (LEVOFLOXACIN SOLUTION FOR INHALATION) TREATMENT OF CHRONIC PULMONARY INFECTIONS.FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. VOL. 61. ISSUE 2. P. 141 -146 | 12 | 67% | 16 |
| 10 | HUANG, HC , SHIEH, CC , YU, WL , CHENG, KC , CHEN, CC , CHANG, ST , CHUANG, YC , (2008) COMPARING THE PROTECTIVE EFFECTS OF CIPROFLOXACIN, MOXIFLOXACIN AND LEVOFLOXACIN IN MICE WITH LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURIES.RESPIROLOGY. VOL. 13. ISSUE 1. P. 47 -52 | 15 | 54% | 8 |
Classes with closest relation at Level 1 |